Welcome to our dedicated page for TILRAY BRANDS news (Ticker: TLRY), a resource for investors and traders seeking the latest updates and insights on TILRAY BRANDS stock.
Tilray Brands Inc. (TLRY) maintains a dynamic presence in global cannabis markets through its medical research initiatives and consumer product innovations. This resource provides investors and industry observers with centralized access to verified corporate announcements, regulatory developments, and market analysis.
Users will find updates spanning earnings reports, international expansion efforts, and product portfolio enhancements, including developments in cannabis-infused wellness solutions. The curated selection enables stakeholders to track operational milestones across Tilray's pharmaceutical-grade production facilities and lifestyle brand divisions.
All content undergoes strict verification to ensure alignment with financial disclosure standards and industry regulations. Regular updates reflect Tilray's position as a GMP-certified producer serving medical markets in 20+ countries while expanding recreational offerings in emerging markets.
Bookmark this page for streamlined monitoring of Tilray's strategic initiatives, quality control advancements, and responses to evolving cannabis legislation worldwide.
Tilray Brands (Nasdaq: TLRY) will implement a 1-for-10 reverse stock split, effective at 4:01 pm ET on December 1, 2025, with shares trading on a split-adjusted basis on December 2, 2025 under the same ticker TLRY and new CUSIP 88688T209.
Every ten issued and outstanding shares will be combined into one share, reducing outstanding common stock from approximately 1.16 billion to 116 million. Fractional shares will be paid in cash. The company said the split aims to align share count with peers, attract institutional investors, and reduce annual meeting costs by up to $1 million on a run-rate basis. Stockholders of record will receive transaction statements; brokerage positions will be adjusted automatically.
Tilray (Nasdaq: TLRY) announced on November 24, 2025 the introduction of Good Supply vape products in Québec after the provincial launch of legal cannabis vaping.
The brand will offer 1 g 510-thread cartridges in Pineapple Express (Hybrid) and Blue Dream (Sativa), compatible with standard 510 batteries. Cartridges use THC distillate blended with cannabis terpenes; Pineapple Express lists dominant terpenes myrcene, humulene, and linalool, while Blue Dream lists myrcene, linalool, and humulene. Products will be sold in-store and online and are stated to comply with provincial regulations.
Tilray Brands (NASDAQ: TLRY) published an updated investor presentation on Nov 17, 2025 outlining its strategic growth roadmap as a diversified consumer packaged goods company across beverages, cannabis and wellness. The presentation emphasizes brand portfolio diversity, operational excellence, margin enhancement, disciplined capital allocation and global expansion across North America, Europe and emerging markets. Management frames the plan as scaling the global footprint, improving financial performance milestones and driving long-term shareholder value. The presentation is available on Tilray Brands' investor relations website under Events & Presentations.
Tilray Brands (NASDAQ: TLRY) brand Pub Beer has partnered with the arcade game Big Buck Hunter to launch Cheap Fun Hunting SZN, a seasonal marketing campaign announced November 13, 2025. The activation includes a limited-edition "Hunter Orange" Pub Beer can, an exclusive merchandise collection, and a sweepstakes for a custom Pub Beer–branded Big Buck Hunter arcade machine valued at over $10,000.
The Pub Beer Hunting Season Sweepstakes is open to legal residents of AZ, CA, ID, NV, OR, UT, and WA aged 21+ and runs through November 30, 2025 at 11:59 p.m. ET. No purchase is necessary; prizes available while supplies last. Always enjoy responsibly.
Tilray Brands (NASDAQ: TLRY) urged Congress to adopt a federal hemp framework and a taxed pathway for hemp-derived THC products while rejecting prohibitionist measures in the recent government funding bill dated November 11, 2025. Tilray supports a federal baseline with state flexibility and endorses a 10 mg naturally derived delta-9 THC per serving cap for hemp beverages. The company said hemp-derived THC beverages represent a $1 billion U.S. industry, are not material to Tilray’s revenue or adjusted EBITDA today, and called for collaboration during the bill’s one-year implementation period to protect consumers and support small businesses.
Tilray Medical (NASDAQ: TLRY) announced updates to its Canadian pricing programs on November 4, 2025 to broaden access to medical cannabis for patients, seniors, first responders, pediatric patients, veterans and those facing financial challenges.
The Compassionate Pricing annual income eligibility was increased to CAD 65,000 from CAD 32,500. Applicants must submit a Notice of Assessment for the most recent taxation year to info@tilraymedical.com. Programs continue to include promotional campaigns, Seniors Pricing, First Responders Appreciation, Frontline Workers Appreciation, Pediatric Pricing and Warrior Wellness for Veterans. More details are available at www.tilraymedical.ca.
Tilray Brands (NASDAQ: TLRY) will debut select craft beer brands in Japan at the American Craft Beer Experience Festival in Tokyo’s Hibiya Park from November 22–24, 2025. The company will operate a dedicated booth pouring tap-only selections from 10 Barrel Brewing Co. (Cloud Mentality, Apocalypse IPA), Green Flash Brewing Co. (West Coast IPA) and Alpine Beer Company (Duet IPA).
Tilray said the appearance supports its strategy to expand the beverage business in Asia via the Brewers Association’s Export Development Program, aiming to engage industry leaders, media and consumers and to showcase brewing techniques and flavor profiles.
Redhook Brewing (TLRY) launched Redhook 81 on Oct 23, 2025: a 4.2% ABV light lager with a retro can design aimed at post‑shift relaxation.
Available now in 16oz 12‑packs and 4‑packs where Redhook is sold. A promotional Redhook Grizzly Sweepstakes runs through Nov 30, 2025 at 11:59 p.m. ET, open to legal residents of Idaho, Oregon, and Washington aged 21+, offering a Quittin’ Time Kit and a 4‑pack of Redhook 81.
Tilray Brands (Nasdaq: TLRY) marked seven years since Canada legalized cannabis, reiterating its position as Canada's largest legal cannabis company by revenue and highlighting market-leading brands and product categories. The company cites >C$1 billion invested in Canadian infrastructure, ~C$700 million paid in excise taxes, ownership of 15 leading brands (several retail-valued C$100M–C$300M), and Q1FY26 operational strength.
Tilray reports 5 million sq ft cultivation capacity, current production of 210 metric tons, and >40% beverage market share for XMG/Mollo.
Tilray Medical (NASDAQ: TLRY) announced an expansion into Panama via a joint venture with Top Tech Global Inc., forming Solana Life Group.
Solana Life Group received a medical cannabis license from the National Directorate of Pharmacy and Drugs in Panama authorizing cultivation, manufacturing, import, export, distribution, and sale of medical cannabis. Tilray Medical said it will provide product supply, education, and support to the Panamanian medical community while collaborating with healthcare professionals, regulators, and patient groups to deliver cannabinoid-based therapies.
FAQ
What is the current stock price of TILRAY BRANDS (TLRY)?
What is the market cap of TILRAY BRANDS (TLRY)?
